Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

19.12
+0.40002.14%
Post-market: 19.200.0800+0.42%19:30 EDT
Volume:1.57M
Turnover:29.93M
Market Cap:3.72B
PE:-38.18
High:19.24
Open:18.73
Low:18.58
Close:18.72
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:193.53M
Volume Ratio:0.73
T/O Rate:0.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.02
PE(LYR):-11.80

Loading ...

Sector Update: Healthcare Stocks Advance Late Afternoon

MT Newswires Live
·
Aug 13

Legend Biotech Shares Fall After Oppenheimer Downgrade

MT Newswires Live
·
Aug 13

Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says

MT Newswires Live
·
Aug 12

Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says

MT Newswires Live
·
Aug 12

Legend Biotech Price Target Cut to $58.00/Share from $59.00 by RBC Capital

Dow Jones
·
Aug 12

Legend Biotech Corp. : Oppenheimer Cuts to Perform from Outperform

THOMSON REUTERS
·
Aug 12

Goldman Sachs Reaffirms Their Buy Rating on Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating

MT Newswires Live
·
Aug 12

U.S. Research Roundup-Cardinal Health, Lumentum Holdings, Public Storage

Reuters
·
Aug 12

Legend Biotech Corporation : TD Cowen Cuts Target Price to $24 from $29

THOMSON REUTERS
·
Aug 12

TD Cowen Sticks to Its Hold Rating for Legend Biotech (LEGN)

TIPRANKS
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Immunic (IMUX), Legend Biotech (LEGN) and Sagimet Biosciences, Inc. Class A (SGMT)

TIPRANKS
·
Aug 12

U.S. Stocks on the MOVEX-Abbott, Columbia Financial, Jabil,

Reuters
·
Aug 11

Legend Biotech Shares Rise After Swinging to 2Q Profit, Higher Revenue

Dow Jones
·
Aug 11

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Reuters
·
Aug 11

GenScript Biotech Announces Legend Biotech Form 6-K for Q2 Ended June 30, 2026

Reuters
·
Aug 11

Legend Biotech Rises After Second Quarter Results Beat Estimates

Reuters
·
Aug 11

Legend Biotech Shares Rise 4.1% Premarket After Q2 Revenue Beat

THOMSON REUTERS
·
Aug 11

Legend Biotech Q2 Revenue Beats Estimates on Commercial Expansion

Reuters
·
Aug 11